Is HSDB 8022 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use HSDB 8022? Is HSDB 8022 safe for nursing mother and child? Does HSDB 8022 extracts into breast milk? Does HSDB 8022 has any long term or short term side effects on infants? Can HSDB 8022 influence milk supply or can HSDB 8022 decrease milk supply in lactating mothers?
HSDB 8022 lactation summary
- DrLact safety Score for HSDB 8022 is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of HSDB 8022 is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that HSDB 8022 does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of HSDB 8022 safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About HSDB 8022 usage in lactation
Alpha-glucosidase inhibitor which acts within the gastrointestinal tract without being absorbed, reducing intestinal absorption of glucose. Very low risk of hypoglycemia in monotherapy. HSDB 8022 is excreted in breast milk in minute quantities (Serrano 2014, Pfizer 2012, AEMPS 2009) reaching a relative dose much less than 1%. Diet, exercise, and breastfeeding improve blood sugar levels.
Answer by DrLact: About HSDB 8022 usage in lactation
Limited data indicate that HSDB 8022 is poorly excreted into breastmilk. Because HSDB 8022 is also poorly absorbed orally, it is unlikely to adversely affect the breastfed infant.
Alternate Drugs
Insulin(Safe)
Empagliflozin(Unsafe)
Glyburide(Safe)
Dapagliflozin(Unsafe)
Glipizide(Safe)
Alogliptin(Low Risk)
Glimepiride(Unsafe)
Linagliptin(Low Risk)
Chlorpropamide(Low Risk)
Sitagliptin(Low Risk)
Acetohexamide(Low Risk)
Saxagliptin(Low Risk)
Acarbose(Safe)
Colesevelam(Safe)
Miglitol(Safe)
Tolbutamide(Safe)
Dulaglutide(Low Risk)
Rosiglitazone(Low Risk)
Repaglinide(Unsafe)
Liraglutide(Low Risk)
Pioglitazone(Low Risk)
Nateglinide(Unsafe)
Metformin(Safe)